Similar articles

• Revised Antituberculosis Drug Doses and Hepatotoxicity in HIV Negative Children.

  Indumathi CK, Sethuraman A, Jain S, Krishnamurthy S. Indumathi CK, et al. Indian J Pediatr. 2019 Mar;86(3):229-232. doi: 10.1007/s12098-018-2812-z. Epub 2018 Dec 4. Indian J Pediatr. 2019. PMID: 30515702
• Evaluation of Risk Factors for Development of Anti-Tubercular Therapy Induced Hepatotoxicity: A Prospective Study.

  Subbalaxmi MVS, Soanker R, Lakshmi AV. Subbalaxmi MVS, et al. Curr Drug Saf. 2020;15(3):198-204. doi: 10.2174/1574886315666200626164554. Curr Drug Saf. 2020. PMID: 32589563
• Hepatotoxicity associated with first-line antitubercular drugs in children at a tertiary care facility.

  Singh A, Meena P, Dabas A, Yadav S, Agarwal A, Khanna V, Khanna A. Singh A, et al. Indian J Tuberc. 2022 Jan;69(1):1-3. doi: 10.1016/j.ijtb.2021.06.008. Epub 2021 Jun 17. Indian J Tuberc. 2022. PMID: 35074139 No abstract available.
• [Gastrointestinal and hepatic side effects of drugs].

  Meier PJ, Fricker R. Meier PJ, et al. Ther Umsch. 1987 Dec;44(12):960-7. Ther Umsch. 1987. PMID: 3327190 Review. German. No abstract available.
• Gastrointestinal and liver side effects of drugs in elderly patients.

  Triantafyllou K, Vlachogiannakos J, Ladas SD. Triantafyllou K, et al. Best Pract Res Clin Gastroenterol. 2010 Apr;24(2):203-15. doi: 10.1016/j.bpg.2010.02.004. Best Pract Res Clin Gastroenterol. 2010. PMID: 20227033 Review.